Evidence map›Paper›PMID 42653749›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Chemical Profiling and Redox-Target Mapping of Antioxidant Fractions from

Esraa A Taema, Wafaa H B Hassan, Eman Fikry, May Ahmed El-Sayed, Asmaa M Arafa, Shaza M Al-Massarani, Wael M Abdelmageed, Omar A Basudan, Afaf E Abdel Ghani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Esraa A TaemaDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Wafaa H B HassanDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Eman FikryDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-4434-2075
May Ahmed El-SayedDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Asmaa M ArafaDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-2900-7279
Shaza M Al-MassaraniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-6298-7205
Wael M AbdelmageedDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Saint Paul, MN 55108, USA.
Omar A BasudanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-3056-841X
Afaf E Abdel GhaniDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.

Funding

King Saud University ORF-2026-1679
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADMEantioxidant activitychalconeflavanonein silico analysisoxidative stressSphagneticola trilobataUPLC–ESI–MS/MSWedelia trilobata

Identifiers

PMID42653749
PMCPMC13516535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.